- Home
- VIR vs EDN Comparison
VIR vs EDN Comparison
Compare VIR & EDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- EDN
- Stock Information
- Founded
- VIR 2016
- EDN 1992
- Country
- VIR United States
- EDN Argentina
- Employees
- VIR 408
- EDN N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- EDN Electric Utilities: Central
- Sector
- VIR Health Care
- EDN Utilities
- Exchange
- VIR Nasdaq
- EDN Nasdaq
- Market Cap
- VIR 706.4M
- EDN 1.2B
- IPO Year
- VIR 2019
- EDN 2007
- Fundamental
- Price
- VIR $5.54
- EDN $27.96
- Analyst Decision
- VIR Strong Buy
- EDN
- Analyst Count
- VIR 7
- EDN 0
- Target Price
- VIR $32.86
- EDN N/A
- AVG Volume (30 Days)
- VIR 1.1M
- EDN 84.8K
- Earning Date
- VIR 07-31-2025
- EDN 08-05-2025
- Dividend Yield
- VIR N/A
- EDN N/A
- EPS Growth
- VIR N/A
- EDN N/A
- EPS
- VIR N/A
- EDN 0.21
- Revenue
- VIR $20,861,000.00
- EDN $2,097,707,542.00
- Revenue This Year
- VIR N/A
- EDN $51.74
- Revenue Next Year
- VIR N/A
- EDN N/A
- P/E Ratio
- VIR N/A
- EDN $6.13
- Revenue Growth
- VIR N/A
- EDN 37.57
- 52 Week Low
- VIR $4.32
- EDN $13.78
- 52 Week High
- VIR $14.45
- EDN $51.69
- Technical
- Relative Strength Index (RSI)
- VIR 58.23
- EDN 46.82
- Support Level
- VIR $5.20
- EDN $24.73
- Resistance Level
- VIR $5.49
- EDN $27.34
- Average True Range (ATR)
- VIR 0.25
- EDN 1.36
- MACD
- VIR 0.03
- EDN 0.16
- Stochastic Oscillator
- VIR 88.73
- EDN 68.72
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About EDN Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor)
Empresa Distribuidora y Comercializadora Norte SA is engaged in the distribution and sale of electricity. The firm's concession area covers the northern portion of the city of Buenos Aires mainly to residential, commercial, industrial, and public service.